BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4273807)

  • 21. The action of vasoactive substances on the microvasculature of the hamster cheek pouch.
    Litton A; Walter CW; Berman HJ
    Bibl Anat; 1967; 9():50-4. PubMed ID: 4291517
    [No Abstract]   [Full Text] [Related]  

  • 22. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Linde M; Mellberg A; Dahlöf C
    Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new serotonin antagonist derived from lysergic acid in the therapy of hemicrania].
    Franchi G; Fanciullacci M
    Minerva Med; 1969 Oct; 60(87):4313-21. PubMed ID: 5354511
    [No Abstract]   [Full Text] [Related]  

  • 24. ["Headache World 2000". The most recent therapy strategies in headache].
    Straube A
    MMW Fortschr Med; 2000 Sep; 142(39):42-3. PubMed ID: 11072697
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of sinus headache as migraine: the diagnostic utility of triptans.
    Kari E; DelGaudio JM
    Laryngoscope; 2008 Dec; 118(12):2235-9. PubMed ID: 18948830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Variations of sensitivity to 5-HT and catecholamines during migraine attacks. Test of venoconstriction].
    Sicuteri F; Del Bianco PL; Fanciullacci M
    Boll Soc Ital Biol Sper; 1966 Jul; 42(13):843-4. PubMed ID: 5967358
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the vasomotor activities of weak doses of 5-hydroxytryptamine in the rat].
    Cession-Fossion A; Lecomte J
    Rev Belg Pathol Med Exp; 1965 Aug; 31(4):285-95. PubMed ID: 5853908
    [No Abstract]   [Full Text] [Related]  

  • 28. [The importance of central monoaminergic mechanisms in the effect of pharmacologic substances on the reflex reactions of the heart].
    Kaverina NV; Mirzoian RS; Rozonov IuB
    Biull Eksp Biol Med; 1967 Jun; 63(6):59-64. PubMed ID: 4393562
    [No Abstract]   [Full Text] [Related]  

  • 29. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoneuroactive substances in migraine.
    Sicuteri F
    Headache; 1966 Oct; 6(3):109-26. PubMed ID: 5918290
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of venoconstriction induced by 5-hydroxytryptamine in man by methysergide (UMI-491) and other serotonin antagonists].
    Sicuteri F; Fanciullacci M; Del Bianco PL; Franchi G
    Boll Soc Ital Biol Sper; 1964 Oct; 40(19):1151-2. PubMed ID: 5877110
    [No Abstract]   [Full Text] [Related]  

  • 32. [Physiopathology of migraine].
    Pascual J; Castro ME
    Neurologia; 1998 Jan; 13(1):29-32. PubMed ID: 9522580
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug dependence and withdrawal in chronic pain patients].
    Wörz R
    Fortschr Med; 1994 Jun; 112(16):229-31. PubMed ID: 8070745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin, and pain.
    Moldofsky H
    Adv Neurol; 1982; 33():51-7. PubMed ID: 6948519
    [No Abstract]   [Full Text] [Related]  

  • 35. A putative 5-HT central feedback in migraine and cluster headache attacks.
    Salmon S; Bonciani M; Fanciullacci M; Marianelli L; Michelacci S; Sicuteri F
    Adv Neurol; 1982; 33():265-74. PubMed ID: 7055005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zolmitriptan (Zomig).
    Rapoport AM; Bigal ME; Tepper SJ; Sheftell FD
    Expert Rev Neurother; 2004 Jan; 4(1):33-41. PubMed ID: 15853613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current concepts of migraine pathogenesis.
    Lance JW
    Neurology; 1993 Jun; 43(6 Suppl 3):S11-5. PubMed ID: 8502382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasomotor paralysis in migraine.
    Simard D; Pechadre JC; Paulson OB
    Trans Am Neurol Assoc; 1973; 98():161-2. PubMed ID: 4784927
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of p-chlorophenylalanine and brain lesions on pain sensitivity and morphine analgesia in the rat.
    Harvey JA; Schlosberg AJ; Yunger LM
    Adv Biochem Psychopharmacol; 1974; 10():233-45. PubMed ID: 4276954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.